Search results

Order by most recent / most popular / relevance

Results: 11-20 of 454

Dispelling the Myriad gene patent harmonization myth

Foley & Lardner LLP
-
Australia, Canada, European Union, France, Germany, Japan, USA
-
April 30 2013

In the wake of the Supreme Court oral arguments in the Myriad "gene patent" case, most commentators are predicting that the Court will uphold the

Video interview: discussing the Supreme Court’s oral arguments in Myriad gene patenting case

Foley & Lardner LLP
-
USA
-
April 25 2013

Earlier this week, I had the opportunity to speak again with Colin O'Keefe of LXBN regarding last week's oral arguments in Association for Molecular

Federal Circuit finds Yaz patent obvious

Foley & Lardner LLP
-
USA
-
April 25 2013

In Bayer Healthcare Pharmaceuticals, Inc. v. Watson Pharmaceuticals, Inc., the Federal Circuit reversed the district court and held that Bayer's

Federal Circuit finds prosecution history disclaimer in enablement arguments

Foley & Lardner LLP
-
USA
-
April 23 2013

In Biogen Idec, Inc. v. GlaxoSmithKline LLC, the Federal Circuit upheld a narrow claim interpretation based on prosecution history disclaimer. The

Challenging the enabling quality of Prior Art

Foley & Lardner LLP
-
USA
-
April 18 2013

In In re Morsa, the Federal Circuit reversed an anticipation rejection where the applicant had challenged the enabling quality of the cited prior art

Supreme Court hears oral arguments in "ACLUMyriad" gene patenting case

Foley & Lardner LLP
-
USA
-
April 15 2013

On April 15, 2013, the Supreme Court heard oral arguments in one of the most controversial and publicized biotech patent cases, the "ACLUMyriad"

Personalized medicine and the gene patenting debate

Foley & Lardner LLP
-
USA
-
April 15 2013

The transcript for today's Supreme Court oral argument in The Association for Molecular Pathology v. Myriad Genetics, Inc., No. 12-398 (2013) has

Supreme Court oral arguments in ACLU Myriad gene patent case

Foley & Lardner LLP
-
USA
-
April 15 2013

On April 15, 2013, the Supreme Court heard oral arguments in one of the most controversial and publicized biotech patent cases-the "ACLUMyriad" gene

“Human genes” and patents

Foley & Lardner LLP
-
USA
-
April 14 2013

At 10:00 A.M. on April 15th, the U.S. Supreme Court will entertain oral arguments in the dispute now known as the human "gene patenting" case. The

Federal Circuit finds patent marking is circumstantial evidence of infringement

Foley & Lardner LLP
-
USA
-
April 11 2013

In Frolow v. Wilson Sporting Goods Co., the Federal Circuit refused to adopt the doctrine of marking estoppel, but held that evidence that Wilson had

< back next >

Search results

Dispelling the Myriad gene patent harmonization myth

Video interview: discussing the Supreme Court’s oral arguments in Myriad gene patenting case

Federal Circuit finds Yaz patent obvious

Federal Circuit finds prosecution history disclaimer in enablement arguments

Challenging the enabling quality of Prior Art

Supreme Court hears oral arguments in "ACLUMyriad" gene patenting case

Personalized medicine and the gene patenting debate

Supreme Court oral arguments in ACLU Myriad gene patent case

“Human genes” and patents

Federal Circuit finds patent marking is circumstantial evidence of infringement

Current Search

Suggested Facets

Author

Jurisdiction

Workarea